From knockout endeavors targeting genes such as FAT1, ATM, PTEN, and GLI1 to deciphering the roles of PDPN, IGFBP3, and CHAF1A through knockdown and knock-in approaches, the studies presented here collectively broaden our understanding of the complex molecular orchestration shaping GBM progression. The gene discussed is GLI1; the disease is glioblastoma.